NAVA SWITCH LNP
Live / Allowed — Notice of allowance issued (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99507745
- Mark type
- Stylized text
- Filed
- 20 Nov 2025
- Published for opposition
- 26 May 2026
- Attorney of record
- Douglas R. Wolf
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations, namely, lipids for drug delivery and research; pharmaceutical preparations, namely, nanoparticles for use in gene therapy, drug delivery, medical research; pharmaceutical preparations, namely, lipid nanoparticles; pharmaceutical preparations, namely, lipid nanoparticles for the delivery of nucleic acid-based therapeutics; pharmaceutical preparations, namely, targeted lipid nanoparticles
Owner
- Nava Therapeutics, Inc., Cambridge, MA, US
- Nava Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 21 Jul 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 May 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 May 2026 — PUBLISHED FOR OPPOSITION
- 20 May 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Apr 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 23 Apr 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 23 Apr 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 23 Apr 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2026 — NON-FINAL ACTION E-MAILED
- 27 Mar 2026 — NON-FINAL ACTION WRITTEN
- 26 Mar 2026 — ASSIGNED TO EXAMINER
- 25 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 20 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 20 Nov 2025 — NEW APPLICATION ENTERED